These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 4603350)

  • 1. [Assessment of the severity of psychiatric states].
    Heimann H; Schmocker A
    Arzneimittelforschung; 1974 Jul; 24(7):1004-6. PubMed ID: 4603350
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study).
    McLaughlin BE
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
    Vandecasteele AJ; Vereecken JL
    Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and EEG investigations with CI-579 and CI-600 (quantitative pharmacoelectroencephalography and "sleep prints").
    Itil TM; Saletu B; Gannon P; Arat M; Hsu W
    Behav Neuropsychiatry; 1973; 4-5(11-12, 1-6):61-8 passim. PubMed ID: 4583772
    [No Abstract]   [Full Text] [Related]  

  • 5. A transcultural study with clomacran: comparison of two assessment methods.
    Ban TA; Lehmann HE; Galvan L; Pecknold JC; Climan M
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):971-89. PubMed ID: 4214672
    [No Abstract]   [Full Text] [Related]  

  • 6. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
    Cocito E; Ambrosini G; Arata A; Bevilacqua P; Tortora E
    Arzneimittelforschung; 1970 Aug; 20(8):1119-25. PubMed ID: 4921409
    [No Abstract]   [Full Text] [Related]  

  • 8. Lithium combined with neuroleptics in the treatment of chronic schizophrenia.
    Kellams JJ; Small JG; Milstein V; Perex HC
    Psychopharmacol Bull; 1976 Apr; 12(2):27-30. PubMed ID: 769024
    [No Abstract]   [Full Text] [Related]  

  • 9. A clinical evaluation of clopenthixol.
    Yaryura-Tobias JA; Wolpert A; White L; Agola P; Merlis S
    Curr Ther Res Clin Exp; 1970 May; 12(5):271-9. PubMed ID: 4986242
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Clomacran in the treatment of schizophrenic patients--a comparison of two assessment methods.
    Galvan L; Torres A; Nieto D
    Psychopharmacol Bull; 1976 Jan; 12(1):30-1. PubMed ID: 1108081
    [No Abstract]   [Full Text] [Related]  

  • 11. Simplified symptom registration in psychiatric trials: a statistical approach.
    Hansen V; Hagen AS; Lehmann EH; Astrup C
    Acta Psychiatr Scand; 1974; 50(5):492-5. PubMed ID: 4156625
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxypertine in schizophrenic psychoses. Controlled clinical trial in two psychiatric hospitals.
    Vinar O; Hamouz V; Bastecký J
    Act Nerv Super (Praha); 1968 Oct; 10(3):315-7. PubMed ID: 4883240
    [No Abstract]   [Full Text] [Related]  

  • 13. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
    Angus JW; Go SH; Simpson GM
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
    [No Abstract]   [Full Text] [Related]  

  • 14. Baclofen treatment in chronic schizophrenia: a clinical trial.
    Bigelow LB; Nasrallah H; Carman J; Gillin JC; Wyatt RJ
    Am J Psychiatry; 1977 Mar; 134(3):318-20. PubMed ID: 320885
    [No Abstract]   [Full Text] [Related]  

  • 15. Examinations on the antidepressive effect of teperin using objective evaluation methods.
    Orosz V; Magyar M; Fenyvesi T
    Ther Hung; 1974; 22(2):60-4. PubMed ID: 4608357
    [No Abstract]   [Full Text] [Related]  

  • 16. Methodological considerations in evaluating antianxiety drugs.
    Hollister LE
    J Clin Pharmacol J New Drugs; 1970; 10(1):12-8. PubMed ID: 4903952
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidepressant effects of an acridane.
    O'Connell RA
    Int Pharmacopsychiatry; 1971; 6(1):1-3. PubMed ID: 4950291
    [No Abstract]   [Full Text] [Related]  

  • 18. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychopharmacologic study of 8909 RP (Neuleptil) by Wittenborn's Psychiatric Status Rating Scale].
    Beauseigneur-Nuyts T; Vallet R; Le Viet MQ
    Encephale; 1964; 53(3):405-14. PubMed ID: 4388707
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled study of fluspirilene in chronic schizophrenia.
    Villeneuve A; Dogan K; Lachance R; Proulx C
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):819-27. PubMed ID: 4994687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.